Bmo capital markets articles
-
BMO Capital Markets Reiterates “Outperform” Rating for Pfizer (NYSE:PFE)
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at BMO Capital Markets in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $36.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $33.00. BMO Capital Markets’ […]
-
Waste Management (NYSE:WM) PT Raised to $212.00 at BMO Capital Markets
Waste Management (NYSE:WM – Get Free Report) had its price objective increased by BMO Capital Markets from $207.00 to $212.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has a “market perform” rating on the business services provider’s stock. BMO Capital Markets’ target price indicates a potential […]
-
BMO Capital Markets Raises Clean Harbors (NYSE:CLH) Price Target to $230.00
Clean Harbors (NYSE:CLH – Free Report) had its target price hoisted by BMO Capital Markets from $225.00 to $230.00 in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the business services provider’s stock. CLH has been the topic of a number of other research […]